Melatonin attenuates phenytoin sodium-induced DNA damage

References

• Ames BN, Shigenaga M, Gold LS. (1993). DNA lesions, inducible DNA repair and cell division: three key factors in mutagenesis and carcinogenesis. Environ Health Perspect 101:35–44
   PubMed Web of Science ®Google Scholar
• Bittigau P, Sifringer M, Ikonomidou C. (2003). Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci 993:103–114
   PubMed Web of Science ®Google Scholar
• Bhuller Y, Wells PG. (2006). A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture. Toxicol Sci 93:156–163
   PubMed Web of Science ®Google Scholar
• Bhuller Y, Jeng W, Wells PG. (2006). Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice. Toxicol Sci 93:146–155
   PubMed Web of Science ®Google Scholar
• Cheung RT, Tipoe GL, Tam S, et al. (2006). Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration. J Pineal Res 41:337–343
   PubMed Web of Science ®Google Scholar
• Collins A, Dusinska M, Franklin M, et al. (1997). Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mutagen 30:139–146
   PubMed Web of Science ®Google Scholar
• Dziegiel P, Suder E, Surowiak P, et al. (2002). Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. J Pineal Res 33:95–100
   PubMed Web of Science ®Google Scholar
• Galano A, Tan DX, Reiter RJ. (2011). Melatonin as a naturally against oxidative stress: a physicochemical examination. J Pineal Res 51:1–16
   PubMed Web of Science ®Google Scholar
• Gitto E, Karbownik M, Reiter RJ, et al. (2001a). Effects of melatonin treatment in septic newborns. Pediatr Res 50:756–760
   PubMed Web of Science ®Google Scholar
• Gitto E, Tan DX, Reiter RJ, et al. (2001b). Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in rat liver homogenates. J Pharm Pharmacol 53:1393–1401
   PubMed Web of Science ®Google Scholar
• Hamed SA, Abdullah MM, El-Melegy N. (2004). Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients. J Pharmacol Sci 96:465–473
   PubMed Web of Science ®Google Scholar
• Hara M, Yoshida M, Nishijima H, et al. (2001). Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats. J Pineal Res 30:129–138
   PubMed Web of Science ®Google Scholar
• Hardeland R, Backhaus C, Fadavi A. (2007). Reactions of the NO redox forms NO+, *NO and HNO (protonated NO) with the melatonin metabolite N1-acetyl-5-methoxykynuramine. J Pineal Res 43:382–388
   PubMed Web of Science ®Google Scholar
• Hardeland R, Tan DX, Reiter RJ. (2009). Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 47:109–126
   PubMed Web of Science ®Google Scholar
• Katz I, Kim J, Gale K, Kondratyev A. (2007). Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther 322:494–500
   PubMed Web of Science ®Google Scholar
• Kaul A, Kalla NR, Goyle S. (2001). An altered proliferative response due to the anticonvulsant phenytoin (PHT) in epileptic patients. Teratog Carcinog Mutagen 21:151–164
   PubMedGoogle Scholar
• Kilic E, Kilic U, Reiter RJ, et al. (2004). Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1. J Pineal Res 37:247–251
   PubMed Web of Science ®Google Scholar
• Kilic U, Kilic E, Reiter RJ, et al. (2005). Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res 38:67–71
   PubMed Web of Science ®Google Scholar
• Kilic U, Yilmaz B, Ugur M, et al. (2012). Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia. J Pineal Res 52:228–235
   PubMed Web of Science ®Google Scholar
• Kilic U, Kilic E, Tuzcu Z, et al. (2013). Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway. Nutr Metab (Lond) 10:7 (1--8)
   Google Scholar
• Kim PM, Winn LM, Parman T, et al. (1997). UDP-glucuronosy ltransferase mediated protection against in vitro DNA oxidation and icronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydandoin. J Pharmacol Exp Ther 280:200–209
   PubMed Web of Science ®Google Scholar
• Kopjar N, Miocic S, Ramic S, et al. (2006). Assessment of the radioprotective effects of amifostine and melatonin on human lymphocytes irradiated with gamma-rays in vitro. Arh Hig Rada Toksikol 57:155–163
   PubMedGoogle Scholar
• Lialiaris T, Lyratzopoulos E, Papachristou F, et al. (2008). Supplementation of melatonin protects human lympho cytes in vitro from the genotoxic activity of melphalan. Mutagenesis 23:347–354
   PubMed Web of Science ®Google Scholar
• Lovell DP, Omori T. (2008). Statistical issues in the use of the comet assay. Mutagenesis 23:171–182
   PubMed Web of Science ®Google Scholar
• Lowenstein DH. (1998). Seizures and epilepsy. In: Fauci AS, Martin JB, Braunwald E, et al. eds. Harrison’s principles of internal medicine, 14th ed. New York: McGraw-Hill, 2315–2316
   Google Scholar
• Mahle C, Dasgupta A. (1997). Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin. Life Sci 61:437–443
   PubMed Web of Science ®Google Scholar
• Manda K, Ueno M, Anzai K. (2007). AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 42:386–393
   PubMed Web of Science ®Google Scholar
• Mayo JC, Tan DX, Sainz RM, et al. (2003). Oxidative damage to catalase induced by peroxyl radicals: functional protection by melatonin and other antioxidants. Free Radic Res 37:543–553
   PubMed Web of Science ®Google Scholar
• Murray JC, Hill RM, Hegemier S, et al. (1996). Lymphoblastic lymphoma following prenatal exposure to phenytoin. J Pediatr Hematol Oncol 18:241–243
   PubMed Web of Science ®Google Scholar
• Nava M, Romero F, Quiroz Y, et al. (2000). Melatonin attenuates acute renal failure and oxidative stress induced by mercury chloride in rats. Am J Physiol Renal Physiol 279:910–918
   PubMed Web of Science ®Google Scholar
• Ortiz GG, Benitez-King GA, Rosales-Corral SA, et al. (2008). Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disorders. Curr Neuropharmacol 6:203–214
   PubMed Web of Science ®Google Scholar
• Pei Z, Pang SF, Cheung RT. (2002). Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J Pineal Res 32:168–172
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Osuna C, et al. (2000). Actions of melatonin in the reduction of oxidative stress. J Biomed Sci 7:444–458
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Sainz RM, et al. (2002). Melatonin reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 54:1299–1321
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Manchester LC, et al. (2003). Melatonin: detoxification of oxygen and nitrogen-based toxic reactants. Adv Exp Med Biol 527:539–548
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Leon J, et al. (2005). When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med 230:104–117
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Paredes SD, Manchester LC, et al. (2009). Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 44:175–200
   PubMed Web of Science ®Google Scholar
• Sandal S, Yilmaz B, Carpenter DO. (2008). Genotoxic effects of PCB 52 and PCB 77 on cultured human peripheral lymphocytes. Mutat Res 654:88–92
   PubMed Web of Science ®Google Scholar
• Sener G, Sehirli AO, Altunbas HZ, et al. (2002). Melatonin protects against gentamicin-induced nephrotoxicity in rats. J Pineal Res 32:231–236
   PubMed Web of Science ®Google Scholar
• Singh G, Driever PH, Sander JW. (2005). Cancer risk in people with epilepsy: the role of anti-epileptic drugs. Brain 128:7–17
   PubMed Web of Science ®Google Scholar
• Sun FY, Lin X, Mao LZ, et al. (2002). Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J Pineal Res 33:48–56
   PubMed Web of Science ®Google Scholar
• Tan DX, Chen LD, Poeggeler B, et al. (1993). Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J 1:57–60
   Google Scholar
• Tan DX, Manchester LC, Terron MP, et al. (2007). One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species. J Pineal Res 42:28–42
   PubMed Web of Science ®Google Scholar
• Urata Y, Honma S, Goto S, et al. (1999). Melatonin induces gammaglutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic Biol Med 27:838–847
   PubMed Web of Science ®Google Scholar
• Ustundag A, Duydu Y. (2007). The influence of melatonin and N-acetylcysteine in delta-aminolevulinic acid and lead induced genotoxicity in lymphocytes in vitro. Biol Trace Elem Res 117:53–64
   PubMed Web of Science ®Google Scholar
• Wells PG, Winn LM. (1997). The role of biotransformation in developmental toxicity. In: Sipes IG, McQueen CA, Gandolfi AJ, eds. Comprehensive toxicology. Tarrytown (NY): Pergamon Elsevier Science, 479–497
   Google Scholar
• Wells PG, McCallum GP, Lam KCH, et al. (2010). Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits. Birth Defects Res C Embryo Today 90:103–109
   PubMed Web of Science ®Google Scholar
• Winn LM, Wells PG. (1995). Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity. Mol Pharmacol 48:112–120
   PubMed Web of Science ®Google Scholar
• Winn LM, Wells PG. (1999). Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity. Free Radic Biol Med 26:266–274
   PubMed Web of Science ®Google Scholar
• Winn LM, Kim PM, Nickoloff JA. (2003). Oxidative stress-induced homologous recombination as a novel mechanism for phenytoin-initiated toxicity. J Pharmacol Exp Ther 306:523–527
   PubMed Web of Science ®Google Scholar